These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30738144)

  • 21. Bisphosphonates and bone diseases: past, present and future.
    Heymann D
    Curr Pharm Des; 2010; 16(27):2948-9. PubMed ID: 20722613
    [No Abstract]   [Full Text] [Related]  

  • 22. What do you really need to know about bisphosphonates?
    Goodchild JH; Donaldson M
    Gen Dent; 2018; 66(2):23-26. PubMed ID: 29513230
    [No Abstract]   [Full Text] [Related]  

  • 23. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates and metabolic bone disease in the ICU.
    Hollander JM; Mechanick JI
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):190-5. PubMed ID: 19209471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonates for osteoporosis: benefits and risks.
    Bollerslev J; Harris ST; Leder BZ
    J Clin Endocrinol Metab; 2011 Sep; 96(9):27A, 28A. PubMed ID: 21896893
    [No Abstract]   [Full Text] [Related]  

  • 26. Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.
    Prescrire Int; 2009 Dec; 18(104):247. PubMed ID: 20020572
    [No Abstract]   [Full Text] [Related]  

  • 27. Should bisphosphonates be used in premenopausal women?
    Cohen A
    Maturitas; 2010 May; 66(1):3-4. PubMed ID: 20356692
    [No Abstract]   [Full Text] [Related]  

  • 28. Bisphosphonates for osteoporosis--where do we go from here?
    Whitaker M; Guo J; Kehoe T; Benson G
    N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168
    [No Abstract]   [Full Text] [Related]  

  • 29. Bisphosphonates for osteoporosis.
    Favus MJ
    N Engl J Med; 2010 Nov; 363(21):2027-35. PubMed ID: 21083387
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates beyond their anti-osteoclastic properties.
    Varenna M
    Rheumatology (Oxford); 2014 Jun; 53(6):965-7. PubMed ID: 24273023
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dental health when using bisphosphonates against breast cancer].
    Eikesdal HP; Løes S; Herlofson BB
    Tidsskr Nor Laegeforen; 2014 Aug; 134(15):1451. PubMed ID: 25138400
    [No Abstract]   [Full Text] [Related]  

  • 33. How to use bisphosphonates safely and optimally.
    Jagpal A; Saag KG
    Rheumatology (Oxford); 2018 Nov; 57(11):1875-1876. PubMed ID: 29165674
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiresorptives and osteonecrosis of the jaw.
    Yamashita J; McCauley LK
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonates in metastatic bone disease: renal safety matters.
    Body JJ
    Oncologist; 2005; 10 Suppl 1():1-2. PubMed ID: 16264105
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Innovation of bisphosphonates for improvement of adherence.].
    Takeuchi Y
    Clin Calcium; 2017; 27(2):197-202. PubMed ID: 28123121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All bisphosphonates are (or may not be) the same: potential reasons for clinical differences.
    Miller PD
    J Womens Health (Larchmt); 2010 Apr; 19(4):665-9. PubMed ID: 20415640
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2015 Oct; 73(10):1683-9. PubMed ID: 26529930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology: Discontinuation of bisphosphonates.
    Malden N; Loh S
    Br Dent J; 2017 Jan; 222(2):67-8. PubMed ID: 28127004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.